GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemostemix Inc (OTCPK:HMTXF) » Definitions » Net Interest Income (for Banks)

HMTXF (Hemostemix) Net Interest Income (for Banks)


View and export this data going back to 2015. Start your Free Trial

What is Hemostemix Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Hemostemix Business Description

Industry
Traded in Other Exchanges
Address
707 - 7th Avenue SouthWest, Suite 1150, Calgary, AB, CAN, T2P 3H6
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.